Skip to main content

Table 3 Baseline tumor characteristics in the study population

From: Comparison between RECIST and PERCIST criteria in therapeutic response assessment in cases of lymphoma

 Lymphoma characteristicsNo. of patients
Location
NodalAbsent4 (12.1%)
Supra15 (45.5%)
Supra & infra14 (42.4%)
Extra-nodalAbsent16 (48.5%)
Splenic7 (21.2%)
Oropharyngeal2 (6.1%)
Splenic & hepatic1 (3.0%)
Hepatic & renal1 (3.0%)
Gastric & hepatic1 (3.0%)
Splenic & renal1 (3.0%)
Parapharyngeal1 (3.0%)
Parotid1 (3.0%)
Lung1 (3.0%)
Bone1 (3.0%)
StageI2 (6.1%)
IE1 (3.0%)
II11 (33.3%)
IIE1 (3.0%)
III5 (15.2%)
IIIS7 (21.2%)
IV6 (18.2%)